Home > Financial Ratios > BALAXI PHARMACEUTICALS

BALAXI PHARMACEUTICALS
EV/Core EBITDA

    Back to All Ratios
BALAXI PHARMACEUTICALS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for BALAXI PHARMACEUTICALS
Please provide your vote to see the results

BALAXI PHARMACEUTICALS Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2023Mar2022Mar2021Mar2020Mar2019
   EV/Core EBITDA(x) 8.726.2411.727.914.67

What is the latest EV/Core EBITDA ratio of BALAXI PHARMACEUTICALS ?

The latest EV/Core EBITDA ratio of BALAXI PHARMACEUTICALS is 8.72 based on Mar2023 Consolidated results.
Year EV/Core EBITDA
Mar20238.72
Mar20226.24
Mar202111.72
Mar20207.91
Mar20194.67

How is EV/Core EBITDA of BALAXI PHARMACEUTICALS Trending?

Years EV/Core EBITDA % Change
Mar2023 8.72
39.74
Mar2022 6.24
-46.76
Mar2021 11.72
48.17
Mar2020 7.91
69.38
Mar2019 4.67 -

Other Financial Ratios of BALAXI PHARMACEUTICALS


Compare EV/Core EBITDA ratio of peers of BALAXI PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BALAXI PHARMACEUTICALS ₹667.1 Cr 0.4% 6.8% 12.5% Stock Analytics
ADANI ENTERPRISES ₹327,767.0 Cr -6.6% -12% 55.9% Stock Analytics
REDINGTON ₹16,417.3 Cr -3.7% -5.5% 27.2% Stock Analytics
HONASA CONSUMER ₹13,833.9 Cr 0.3% 4.5% NA Stock Analytics
MMTC ₹10,870.5 Cr -4.3% -1% 161.6% Stock Analytics
MSTC ₹6,099.5 Cr -5.1% -3.9% 197.2% Stock Analytics


BALAXI PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BALAXI PHARMACEUTICALS

0.4%

6.8%

12.5%

SENSEX

0.2%

-0.2%

20.9%


You may also like the below Video Courses